Nona Craig, MD
Dermatology · Skokie, ILNPI 1811097801
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.5% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 30.9% of the total. 2025 is the largest year on record at $615, 2.4 times the $253 reported in 2023. That places this record below the midpoint for dermatology clinicians in IL, where the typical reported total is $1,774.
Across 60 payments — averaging $21.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$407
- Johnson & Johnson$300
- Amgen$98
- Sanofi$84
- Pfizer$82
- LEO Pharma Inc.$73
- plus $274 from 8 others
What the payments were for
- Food & beverage$1,24795%
- Education$725%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $407 |
| Johnson & Johnson | 16 | $300 |
| Amgen | 4 | $98 |
| Sanofi | 3 | $84 |
| Pfizer | 1 | $82 |
| LEO Pharma Inc. | 4 | $73 |
| UCB, Inc. | 2 | $62 |
| Regeneron Healthcare Solutions, Inc. | 2 | $57 |
| Novartis | 2 | $57 |
| Sun Pharmaceutical Industries Inc. | 1 | $22 |
| Organon | 2 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Galderma Laboratories, L.p. | 1 | $18 |
| Verrica Pharmaceuticals Inc. | 1 | $17 |
How this compares
$1,319 in reported general payments places this provider in the 40th percentile of 606 dermatology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metronidazole | 94 | $4,034 |
| CiclopiroxCiclopirox Olamine | 126 | $3,607 |
| Triamcinolone Acetonide | 115 | $1,261 |
| Fluocinonide | 19 | $832 |
| Mupirocin | 73 | $803 |
| Betamethasone Valerate | 23 | $728 |
| Clobetasol Propionate | 28 | $625 |
| Hydrocortisone | 92 | $471 |
| ValacyclovirValacyclovir Hcl | 18 | $171 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Skokie
- Stephanie MehlisSkokie$145K
- Benjamin GardenSkokie$22K
- Ahmad AminNaperville$4.1M
- Raj ChovatiyaChicago$3.6M
- George LewittNorthbrook$3M
- Peter LioChicago$2.4M
- Elizabeth KiracofeChicago$1.6M
- Lana SchmidtEffingham$1.3M
- Melissa AbramsVernon Hills$600K
- Carolyn JacobChicago$566K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.